Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-09-01
|
| Series: | Retrovirology |
| _version_ | 1818274846804541440 |
|---|---|
| author | Goepfert P Elizaga M Montefiori D Hural J DeRosa S Tomaras G Seaton K Sato A Ouedraogo L Donastorg Y Cardinali M Lama J Baden L Keefer M McElrath J Kalams S Robinson H |
| author_facet | Goepfert P Elizaga M Montefiori D Hural J DeRosa S Tomaras G Seaton K Sato A Ouedraogo L Donastorg Y Cardinali M Lama J Baden L Keefer M McElrath J Kalams S Robinson H |
| author_sort | Goepfert P |
| collection | DOAJ |
| first_indexed | 2024-12-12T22:20:21Z |
| format | Article |
| id | doaj.art-ff0825cc96624c06bb2f475b084a1844 |
| institution | Directory Open Access Journal |
| issn | 1742-4690 |
| language | English |
| last_indexed | 2024-12-12T22:20:21Z |
| publishDate | 2012-09-01 |
| publisher | BMC |
| record_format | Article |
| series | Retrovirology |
| spelling | doaj.art-ff0825cc96624c06bb2f475b084a18442022-12-22T00:09:56ZengBMCRetrovirology1742-46902012-09-019Suppl 2O5610.1186/1742-4690-9-S2-O56Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particlesGoepfert PElizaga MMontefiori DHural JDeRosa STomaras GSeaton KSato AOuedraogo LDonastorg YCardinali MLama JBaden LKeefer MMcElrath JKalams SRobinson H |
| spellingShingle | Goepfert P Elizaga M Montefiori D Hural J DeRosa S Tomaras G Seaton K Sato A Ouedraogo L Donastorg Y Cardinali M Lama J Baden L Keefer M McElrath J Kalams S Robinson H Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles Retrovirology |
| title | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_full | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_fullStr | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_full_unstemmed | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_short | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_sort | phase 2a safety and immunogenicity testing of dna and recombinant modified vaccinia ankara virus vaccines expressing virus like particles |
| work_keys_str_mv | AT goepfertp phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT elizagam phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT montefiorid phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT huralj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT derosas phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT tomarasg phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT seatonk phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT satoa phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT ouedraogol phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT donastorgy phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT cardinalim phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT lamaj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT badenl phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT keeferm phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT mcelrathj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT kalamss phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT robinsonh phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles |